TrialEuropean journal of cancer (Oxford, England : 1990)2018

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.

Maeve A Lowery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.